Adebrelimab for uterine cervical neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 28 Jul 2026: Trial registered, NCT07731828

The trials

NCT07731828: Neoadjuvant Short-course Hypofractionated Radiotherapy Plus Adebrelimab and Platinum Chemotherapy in Locally Advanced Cervical Cancer: A Single-arm Phase II Trial

State
Under way
Phase
Phase 2
People
35 planned
Started
1 Aug 2026
Primary completion
1 Aug 2028
Arms
Adebrelimab Treatment
Results
None posted
  1. 28 Jul 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Adebrelimab Injection, Adebrelimab Injection combined with radiotherapy and chemotherapy, Arm 1: Adebrelimab Combined with Chemoradiotherapy Followed by Surgery.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.